Administration of IL-4 prevents autoimmune diabetes but enhances pancreatic insulitis in NOD mice

Clinical Immunology and Immunopathology

Volumn 86, Issue 2, 1998, Pages 209-218

  Tominaga, Yoichi ^a   Nagata, Masao ^a   Yasuda, Hisafumi ^a   Okamoto, Naoko ^a   Arisawa, Kenji ^a   Moriyama, Hiroaki ^a   Miki, Masatoshi ^a   Yokono, Koichi ^a   Kasuga, Masato ^a  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

CD45RB; Suppressor T cell; Th1 Th2 balance

Indexed keywords

CD4 ANTIGEN; CD45 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; MESSENGER RNA; RECOMBINANT INTERLEUKIN 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FLOW CYTOMETRY; HELPER CELL; INSULITIS; MALE; MOUSE; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN CELL; T LYMPHOCYTE;

EID: 0032005416     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1997.4471     Document Type: Article

References (41)

1. Eisenbarth G. S. Type I diabetes mellitus: A chronic autoimmune disease. N. Engl. J. Med. 314:1986;1360-1368.
2. Makino S., Kunimoto K., Muraoka Y., Mizushima Y., Katagiri K., Tochino Y. Breeding of a non-obese diabetic strain of mice. Exp. Anim. 29:1980;1-13.
3. Koike T., Itoh Y., Ishi T., Ito I., Takabayashi K., Maruyama N., Tomioka H., Yoshida S. Preventive effect of monoclonal anti-L3T4 antibody on development of diabetes in NOD mice. Diabetes. 36:1987;539-541.
4. Hutchings P., Rosen H., O'Reilly L., Simpson E., Gordon S., Cooke A. Transfer of diabetes in mice prevented by blockade of adhesion-promoting receptor on macrophages. Nature. 348:1990;639-642.
5. Bendelac A., Boitard C., Bedossa P., Bazin H., Bach J. F., Carnaud C. Adoptive T cell transfer of autoimmune nonobese diabetic mouse diabetes does not require recruitment of host B lymphocytes. J. Immunol. 141:1988;2625-2628.
6. Kanazawa Y., Komeda K., Sato S., Mori S., Akanuma K., Takaku F. Non-obese-diabetic mice: Immune mechanisms of pancreatic β-cell destruction. Diabetologia. 27:1984;113-115.
7. Yokono K., Shii K., Hari J., Yaso S., Imamura Y., Ejiri K., Ishihara K., Fujii S., Kazumi T., Taniguchi H., Baba S. Production of monoclonal antibodies to islet cell surface antigens using hybridization of spleen lymphocytes from non-obese diabetic mice. Diabetologia. 26:1984;379-385.
8. Makino S., Harada M., Kishimoto Y., Hayashi Y. Absence of insulitis and overt diabetes in athymic nude mice with NOD genetic background. Exp. Anim. 35:1986;495-498.
9. ++. Proc. Natl. Acad. Sci. USA. 88:1991;527-531.
10. ++. J. Exp. Med. 166:1987;823-832.
11. Wicker L. S., Miller B. J., Mullen Y. Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice. Diabetes. 35:1986;855-860.
12. +. J. Immunol. 152:1994;2042-2050.
13. Shizuru J. A., Taylor-Edwards C., Banks B. A., Gregory A. K., Fathman C. G. Immunotherapy of the nonobese diabetic mouse: Treatment with an antibody to T-helper lymphocytes. Science. 240:1988;659-662.
14. Mosmann T. R., Cherwinski H., Bond M. W., Giedlin M. A., Coffman R. L. Two types of mouse helper T cell clone. J. Immunol. 136:1986;2348-2357.
15. +. Science. 249:1990;1433-1436.
16. ++. Diabetes. 45:1996;328-336.
17. Katz J. D., Benoist C., Mathis D. T helper cell subsets in insulin-dependent diabetes. Science. 268:1995;1185-1188.
18. Gajewski T. F., Fitch F. W. Anti-proliferative effect of IFN-γ in immune regulation. J. Immunol. 140:1988;4245-4252.
19. Fiorentino D. F., Bond M. W., Mosmann T. R. Two types of mouse T helper cell. J. Exp. Med. 170:1989;2081-2095.
20. Pennline K. J., Roque-Gaffney E., Monahan M. Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. Clin. Immunol. Immunopathol. 71:1994;169-175.
21. Campbell I. L., Kay T. W. H., Oxbrow L., Harrison L. C. Essential role for interferon-γ and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice. J. Clin. Invest. 87:1991;739-742.
22. Rabinovitch A., Sorensen O., Suarez-Pinzon W. L., Power R. F., Rajotte R. V., Bleackley R. C. Analysis of cytokine mRNA expression in syngeneic islet grafts of NOD mice: Interleukin 2 and interferon gamma mRNA expression correlate with graft rejection and interleukin 10 with graft survival. Diabetologia. 37:1994;833-837.
23. Muir A., Peck A., Clare-Salzler M., Song Y. H., Cornelius J., Luchetta R., Krischer J., Maclaren N. Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-γ transcription. J. Clin. Invest. 95:1995;628-634.
24. Swain S. L., Weinberg A. D., English M., Huston G. IL-4 directs the development of Th2-like helper effectors. J. Immunol. 145:1990;3796-3806.
25. Kopf M., Gros G. L., Bachmann M., Lamers M. C., Bluethmann H., Köhler G. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature. 362:1993;245-248.
26. Rapoport M. J., Jaramillo A., Zipris D., Lazarus A. H., Serreze D. V., Leiter E. H., Cyopick P., Danska J. S., Delovitch T. L. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J. Exp. Med. 178:1993;87-99.
27. Arreaza G. A., Cameron M. J., Delovitch T. L. Interleukin-4: Potential immunoregulatory agent in therapy of insulin-dependent diabetes mellitus. Clin. Immunother. 6:1996;251-260.
28. +. Int. Immunol. 4:1992;923-930.
29. low+. Diabetes. 45:1996;71-78.
30. +. J. Exp. Med. 177:1993;627-636.
31. +. J. Immunol. 148:1992;1031-1036.
32. Rabinovitch A., Suarez-Pinzon W., El-Sheikh A., Sorensen O., Power R. F. Cytokine gene expression in pancreatic islet-infiltrating leukocytes of BB rats: Expression of Th1 cytokines correlates with β-cell destructive insulitis and IDDM. Diabetes. 45:1996;749-754.
33. Nicoletti, F. Meroni, P. L. Landolfo, S. Gariglio, M. Guzzardi, S. Barcellini, W. Lunetta, M. Mughini, L. Zanussi, C. Prevention of diabetes in BB/Wor rats treated with monoclonal antibodies to interferon-γ Lancet, 336, 319.
34. Boitard C., Yasunami R., Dardenne M., Bach J. F. T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice. J. Exp. Med. 169:1989;1669-1680.
35. +. J. Exp. Med. 182:1995;87-97.
36. +. J. Immunol. 151:1993;4362-4370.
37. Mcinerney M. F., Pek S. B., Thomas D. W. Prevention of insulitis and diabetes onset by treatment with complete freunds' adjuvant in NOD mice. Diabetes. 40:1991;715-725.
38. Shimada A., Charlton B., Rohane P., Taylor-Edwards C., Fathman C. G. Immune regulation in type 1 diabetes. J. Autoimmun. 9:1996;263-269.
39. Racke M. K., Bonomo A., Scott D. E., Cannella B., Levine A., Raine C. S., Shevach E. M., Röcken M. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J. Exp. Med. 180:1994;1961-1966.
40. Mueller R., Krahl T., Sarvetnick N. Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice. J. Exp. Med. 184:1996;1093-1099.
41. Scott B., Liblau R., Degermann S., Marconi L. A., Ogata L., Caton A. J., Mcdevitt H. O., Lo D. A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity. Immunity. 1:1994;73-82.